Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.79 |
| ▸ | MAPT | P10636 | 2/20 | 0.79 |
| ▸ | MEN1 | O00255 | 2/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.79 |
| ▸ | LMNA | P02545 | 1/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.79 |
| ▸ | VDR | P11473 | 2/20 | 0.65 |
| ▸ | GPBAR1 | Q8TDU6 | 7/20 | 0.63 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.63 |
| ▸ | SLC10A2 | Q12908 | 2/20 | 0.63 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.63 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.59 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.59 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14315480 | 1.00 | USP2 (0.79) | USP2MAPTMEN1KMT2ALMNA | |
| SCHEMBL17578641 | 1.00 | USP2 (0.79) | USP2MAPTMEN1KMT2ALMNA | |
| SCHEMBL17578745 | 1.00 | USP2 (0.79) | USP2MAPTMEN1KMT2ALMNA | |
| SCHEMBL10073740 | 1.00 | USP2 (0.79) | USP2MAPTMEN1KMT2ALMNA | |
| SCHEMBL330008 | 1.00 | USP2 (0.79) | USP2MAPTMEN1KMT2ALMNA | |
| SCHEMBL17898400 | 1.00 | USP2 (0.79) | USP2MAPTMEN1KMT2ALMNA | |
| SCHEMBL7992936 | 1.00 | USP2 (0.79) | USP2MAPTMEN1KMT2ALMNA | |
| SCHEMBL12644507 | 0.95 | USP2 (0.71) | USP2MAPTMEN1KMT2ALMNA | |
| SCHEMBL14570885 | 0.93 | USP2 (0.79) | USP2MAPTMEN1KMT2ALMNA | |
| SCHEMBL5030971 | 0.93 | USP2 (0.79) | USP2MAPTMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10981946-B2 | Methods for the purification of deoxycholic acid | ALLERGAN SALES, LLC (US) | 2021-04-20 | — | — | US | disclosed |
| US-20200095274-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | ALLERGAN SALES, LLC (US) | 2020-03-26 | — | — | US | disclosed |
| US-10472384-B2 | Methods for the purification of deoxycholic acid | ALLERGAN SALES, LLC (US) | 2019-11-12 | — | — | US | disclosed |
| EP-3138850-B1 | COMPOSITIONS CONTAINING DEOXYCHOLIC ACID AND 10% DEIONIZED WATER IN ETHANOL, DIRECTED TO THE PURIFICATION OF DEOXYCHOLIC ACID | KYTHERA BIOPHARMACEUTICALS INC (US) | 2019-08-07 | — | — | EP | disclosed |
| US-20190135855-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | KYTHERA BIOPHARMACEUTICALS, INC. (US) | 2019-05-09 | — | — | US | disclosed |
| US-10005813-B2 | Methods for the purification of deoxycholic acid | KYTHERA BIOPHARMACEUTICALS, INC. (US) | 2018-06-26 | — | — | US | disclosed |
| EP-2513132-B9 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | KYTHERA BIOPHARMACEUTICALS INC (US) | 2017-12-27 | — | — | EP | disclosed |
| US-20170320905-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | KYTHERA BIOPHARMACEUTICALS, INC. (US) | 2017-11-09 | — | — | US | disclosed |
| US-9683007-B2 | Methods for the purification of deoxycholic acid | KYTHERA BIOPHARMACEUTICALS, INC. (US) | 2017-06-20 | — | — | US | disclosed |
| EP-3138850-A1 | COMPOSITIONS CONTAINING DEOXYCHOLIC ACID AND C1-3-ALCOHOLS, DIRECTED TO THE PURIFICATION OF DEOXYCHOLIC ACID | Kythera Biopharmaceuticals, Inc. (US) | 2017-03-08 | — | — | EP | disclosed |
| EP-2721047-B1 | METHODS FOR THE SYNTHESIS AND PURIFICATION OF DEOXYCHOLIC ACID | KYTHERA BIOPHARMACEUTICALS INC (US) | 2016-11-16 | — | — | EP | disclosed |
| EP-3040342-A1 | PURIFIED DEOXYCHOLIC ACID AND ITS COSMETIC USE IN THE NON-SURGICAL REMOVAL OF UNDESIRABLE FAT DEPOSITS | Kythera Biopharmaceuticals, Inc. (US) | 2016-07-06 | — | — | EP | disclosed |
| EP-2513132-B1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | KYTHERA BIOPHARMACEUTICALS INC (US) | 2016-03-09 | — | — | EP | disclosed |
| WO-2012174229-A2 | METHODS FOR THE SYNTHESIS AND PURIFICATION OF DEOXYCHOLIC ACID | KYTHERA BIOPHARMACEUTICALS, INC. (US) | 2012-12-20 | — | — | WO | disclosed |
| WO-2011075701-A2 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | KYTHERA BIOPHARMACEUTICALS, INC. (US) | 2011-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190135855-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | HSD11B1, HSD17B7, HSD17B13 | USP2 2008/4885MAPT 3484/4885MEN1 2399/4885 |
| US-20200095274-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | HSD11B1, HSD17B7, HSD17B13 | USP2 2008/4885MAPT 3484/4885MEN1 2399/4885 |
| US-10005813-B2 | Methods for the purification of deoxycholic acid | HSD11B1, HSD17B7, HSD17B13 | USP2 2008/4885MAPT 3484/4885MEN1 2399/4885 |
| US-10472384-B2 | Methods for the purification of deoxycholic acid | HSD11B1, HSD17B7, HSD17B13 | USP2 2008/4885MAPT 3484/4885MEN1 2399/4885 |
| US-10981946-B2 | Methods for the purification of deoxycholic acid | HSD11B1, HSD17B7, HSD17B13 | USP2 2008/4885MAPT 3484/4885MEN1 2399/4885 |
| US-20170320905-A1 | METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID | HSD11B1, HSD17B7, HSD17B13 | USP2 2008/4885MAPT 3484/4885MEN1 2399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.